New tax will hit branded drugs and active ingredients while exempting generics for at least one year

The Trump administration is preparing to impose new tariffs on drugmakers that have not struck deals with the president to lower their U.S. drug prices.

Drug companies that commit to moving production to the U.S. will face a 20% tariff and no tariff if they also agree to lower prices.